Tag Archives: HEA

Revolutionary X-ray Technology From Australia to Transform American Airport Security

SeaTac chosen for Micro-X Inc’s USA headquarters
Official Opening at 10 am PDT, Friday May 28
855 S 192nd Street, Suite B600, Seattle, WA 98148

With:

  • Congressman Adam Smith, chair of the House Armed Services Committee
  • Brigadier Hugh Meggitt representing Australian Defence Staff, Embassy of Australia
  • Stephen Patterson, South Australian Minister for Trade and Investment (Pre-recorded)
  • Erin Sitterley, SeaTac Mayor

Technology featured:

  • World’s first electronic x-ray tube, using nano technology to create the most significant innovation in x-ray tubes in over 100 years
  • Rover: the first FDA approved system using Micro-X’s revolutionary x-ray technology
  • Prototype self-service baggage scanner, reimagining the future of airport security.

SEATTLE, Wash., May 28, 2021 — Australian company, Micro-X has chosen SeaTac, Washington State, as its US headquarters as it expands its capabilities to better support their rapidly growing business.

The proximity to the Airport for Micro-X’s future airline passenger self-screening development, the exceptional level of software talent in the greater Seattle Region, and the room in south King County for the company’s expansion plans all contributed to SeaTac being chosen as the ideal location.

Micro-X has reinvented how X-rays are generated. Using their patented carbon nanotube X-ray cold emitter technology, they’ve invented Rover, a mobile X-ray machine that weighs less than 220 lbs and is ruggedized for high intensity use in field hospitals and remote locations.

But the technology can do much more. It could transform airport security across America, enabling faster and more reliable X-ray baggage screening, reimagining airport checkpoints.

"Today, we’re expanding our US operations," says Peter Rowland, Micro-X Australian CEO.

"Our new SeaTac facility will be a center of excellence for imaging product development that will revolutionize medical, defense, and security x-ray imaging," says Brian Gonzales CEO of Micro-X’s rapidly expanding US operations.

"Our mobile X-ray machines are available now for use in public and military hospitals. They’re lighter, cheaper, more robust, and more precise than our competitors."

The patented invention that makes all these ideas possible is inside our 3.3 lb x-ray tube which replaces a conventional x-ray tube weighing more than 44 lbs.

Read the full media release at https://micro-x.com/revolutionary-x-ray-technology-from-australia-to-transform-american-hospitals-and-airports/ 

Related Links :

https://micro-x.com/

Neteera makes annual CNBC Disruptor 50 list second year running

JERUSALEM, May 27, 2021Neteera, global leader in contactless vital signs sensing, has been named for the second year running to the CNBC Disruptor 50, an annual list of private venture-backed companies transforming the economy and the way we live. Over 1,500 nominees contended for the prestigious award this year.

The Jerusalem-based startup developed a first-of-its-kind solution to monitor human physiological parameters. The Neteera microsensor presents a contact-free, hands-free, cable-free, and disposables-free approach to safely facilitate rapid and accurate detection of vital signs and biodata in real time, while providing historical data, thereby safeguarding and improving lives. The technology is suitable for the home as well as hospitals and care facilities and Neteera is enabling personalized care worldwide through advanced health management.

Seamless and continuous patient monitoring, with no patient involvement is a long sought-after solution that will significantly simplify understanding of patient status, improve prognosis, and reduce patient stress levels and cost. Neteera’s technology is based on a combination of proprietary micro-radar on chip, algorithms, artificial intelligence, and cloud. There are no cameras and all information obtained is anonymized, providing ultimate privacy.

Isaac Litman, Founder and CEO of Neteera said: "Our naming for the second year in a row to CNBC Disruptor 50 is a clear indication of Neteera’s potential to change healthcare as we know it. Healthcare is rapidly redefining itself and we are proud to be spearheading the drive for safety, comfort, quality and equality of care for all. As one of our customers put it: ‘Neteera should be a part of every clinical care end point, from hospitals, to clinics to home’".

ABOUT NETEERA TECHNOLOGIES

Neteera is a Jerusalem-based hi-tech company with a vision to make healthcare available to all, regardless of how much they are paying for their health coverage. Neteera facilitates healthcare provision from home, hospital or care facilities, supports caregivers by providing a safer work environment, and saves healthcare systems money & resources in patient care, thereby improving and saving lives.

Further information:
www.neteera.com
pr@neteera.com

Related Links :

http://www.neteera.com

Aon’s New Vaccine Supply Chain Solution to Benefit Response Fund for the World Health Organization


Aon will donate all 2021 revenues from new solution that protects global COVID-19 vaccine shipments to the COVID-19 Solidarity Response Fund.

CHICAGO, May 25, 2021 — Aon plc (NYSE: AON), a leading global professional services firm providing a broad range of risk, retirement and health solutions, has announced it will donate 100 percent of all 2021 revenues earned from its new vaccine supply chain solution to the COVID-19 Solidarity Response Fund, powered by the WHO Foundation and the United Nations Foundation in support of the World Health Organization (WHO). Aon commits to donating a minimum of $100,000.

Delivered through broad industry collaboration, Aon’s recently launched solution provides supply chain protection for global COVID-19 vaccine shipments and is designed to help maximize the number of doses that are administered to the public. The solution provides transparent cargo insurance coverage for COVID-19 vaccines and combines sensor data and analytics to deliver timely payment for doses that fall outside of the agreed-upon temperature range while being transported or stored. Qualified parties in the vaccine supply chain are eligible, including pharmaceutical firms, government bodies, transportation and logistics companies, distributors, health systems, pharmacy chains and inoculation centers.

"As we continue to move toward the ‘New Better’ and have seen incredible progress in some areas when it comes to vaccine distribution, the COVID-19 pandemic is still affecting communities around the world in unprecedented ways and its impact will continue to reverberate for years to come," said Greg Case, CEO, Aon. "By benefitting the COVID-19 Solidarity Response Fund, our new collaborative solution is not only providing first-hand support in supply chain management, but also aiding other critical life-saving efforts of the WHO Foundation."

The COVID-19 Solidarity Response Fund for the WHO is the only way for individuals, corporations, foundations and other organizations around the world to directly support the work of the WHO and its partners to help countries prevent, detect and respond to the COVID-19 pandemic. As of May 2021, the fund has put more than $250 million in donations to work. Donations support the WHO’s efforts including suppressing worldwide transmission of the virus, reducing mortality, protecting the vulnerable and accelerating equitable access to new COVID-19 tools.

"Navigating vaccine distribution at a global scale is one of the most immediate and pressing hurdles facing our leaders today," said Paul Kim, Head of Strategy and Product Development, Commercial Risk Solutions at Aon. "It is an honor to support the WHO Foundation to maximize the impact of our efforts. We are proud to not only provide an innovative offering to help work toward equitable global distribution, but to also directly benefit a fund that is impacting communities around the world in the fight against COVID-19."

Learn more about how businesses have shifted in response to the COVID-19 pandemic in Helping Organizations Chart a Course to The New Better.

About Aon
Aon plc (NYSE: AON) is a leading global professional services firm providing a broad range of risk, retirement and health solutions. Our 50,000 colleagues in 120 countries empower results for clients by using proprietary data and analytics to deliver insights that reduce volatility and improve performance.

Follow Aon on Twitter and LinkedIn
Stay up to date by visiting the Aon Newsroom and hear from Aon’s expert advisors in The One Brief.
Sign up for News Alerts here

Aon UK Limited is authorised and regulated by the Financial Conduct Authority for the provision of regulated products and services in the UK. Registered in England and Wales. Registered number: 00210725. Registered Office: The Aon Centre, The Leadenhall Building, 122 Leadenhall Street, London EC3V 4AN. [FP.GBC.381.JJ]. 

Media Contact
Nadine Youssef
mediainquiries@aon.com
Toll-free (U.S., Canada and Puerto Rico): +1 833 751 8114
International: +1 312 381 3024

 

Related Links :

http://www.aon.com

CGTN:China makes new pledges to help developing countries defeat COVID-19

BEIJING, May 22, 2021China on Friday announced several new measures to help developing countries tackle the COVID-19 pandemic and its sweeping impacts, pledging to contribute $3 billion in the next three years and provide more vaccines.

 

Addressing the Global Health Summit via video link, Chinese President Xi Jinping urged the world’s leading economies to remedy deficiencies, close loopholes and strengthen weak links in fighting "the most serious pandemic in a century."

The summit was co-hosted by the European Commission and Italy, chair of the Group of 20 (G20) this year.

The number of confirmed COVID-19 cases worldwide has surpassed 165 million, with more than 3.4 million deaths, according to data from Johns Hopkins University.

‘Close the immunization gap’

"A year ago, I proposed that vaccines should be made a global public good," Xi said. "Today, the problem of uneven vaccination has become more acute."

More than 1.1 billion COVID-19 vaccine doses have been administered globally, but over 80 percent of those were administered in high and upper-middle income countries, with just 0.3 percent of inoculations taking place in low-income countries, Dr. Tedros Adhanom Ghebreyesus, director general of the World Health Organization (WHO), said earlier this month.

China has supplied 300 million doses of vaccines to the world; it has provided free vaccines to more than 80 developing countries in urgent need and exported vaccines to 43 countries, Xi noted, adding that China will provide more vaccines to the best of its ability.

China supports its vaccine companies in transferring technologies to other developing countries and carrying out joint production with them, he said.

Reaffirming China’s support for waiving intellectual property rights on COVID-19 vaccines, he said the country "supports the World Trade Organization and other international institutions in making an early decision on this matter."

He raised a proposal for setting up an international forum on vaccine cooperation to promote fair and equitable distribution of vaccines around the world.

"We must uphold fairness and equity as we strive to close the immunization gap," Xi stressed. "It is imperative for us to reject vaccine nationalism and find solutions to issues concerning the production capacity and distribution of vaccines, in order to make vaccines more accessible and affordable in developing countries."

More financial support

China has already provided $2 billion to help with developing countries’ responses to COVID-19; it has sent medical supplies to more than 150 countries and 13 international organizations, providing more than 280 billion masks, 3.4 billion protective suits and four billion testing kits to the world, according to Xi.

"China will provide an additional $3 billion in international aid over the next three years to support COVID-19 response and economic and social recovery in other developing countries," he announced.

Xi, the leader of the world’s largest developing country, mentioned "developing countries" 11 times in a speech that lasted less than seven minutes, calling on G20 members to do more to help them and address their concerns.

"China is fully implementing the G20 Debt Service Suspension Initiative for Poorest Countries and has so far put off debt repayment exceeding $1.3 billion, the highest deferral amount among G20 members," he said.

It is essential that G20 members continue to support developing countries by such means as debt suspension and development aid, said the Chinese president.

Xi went further to call for improvement in the global governance system. G20 countries should strengthen and leverage the role of the United Nations and the WHO and improve the global disease prevention and control system, the Chinese president said.

"It is important that we uphold the spirit of extensive consultation, joint contribution and shared benefits, fully heed the views of developing countries, and better reflect their legitimate concerns," he added.

Xi repeated his call for solidarity and cooperation in fighting COVID-19 and building a global community of health for all.

"The pandemic is yet another reminder that we, humanity, rise and fall together with a shared future," he said. "We must champion the vision of building a global community of health for all, tide over this trying time through solidarity and cooperation, and firmly reject any attempt to politicize, label or stigmatize the virus."

https://news.cgtn.com/news/2021-05-21/China-makes-new-pledges-to-help-developing-countries-defeat-COVID-19-10rWrYN7HGg/index.html 

 

Related Links :

http://www.cgtn.com

Clubessential Holdings Announces Acquisition of Exerp, ApS

Acquisition of Europe-based Exerp positions Clubessential Holdings, a Battery Ventures-backed investment, as clear global leader in SaaS membership solutions for enterprise fitness operators

CINCINNATI, May 15, 2021 — Clubessential Holdings, the leading provider of enterprise-membership and club-management software solutions to the private- and public-clubs, college-athletic, health and fitness, and parks and recreation markets, today announced the strategic acquisition of Exerp, the market leader in member-management systems for enterprise-fitness operators. Already a major provider of membership- and club-management SaaS solutions for boutique fitness franchisors, under its ClubReady brand, this acquisition expands Clubessential Holdings’ international presence to serving over 6,000 fitness clubs, and 7 million members, in 17 countries.

Exerp, headquartered in Copenhagen, Denmark, specializes in providing enterprise-class membership-management software systems to large, global fitness brands, including Lifetime Fitness, SATS, Virgin Active and PureGym. 40% of the biggest fitness operators in Europe run on Exerp. The Exerp platform acts as the centralized information source and member database for payment collection, bookings reporting, business analytics and customer-relations management. It has been developed over more than 15 years in partnership with their clients and integrates a wealth of best practices from the fitness and leisure industry.

"For the past 15 years, the Exerp team has been on a mission to make the world healthier and happier by shaping the fitness industry," said Rémi Nodet, CEO & CTO, Exerp. "Our goal is to be the trusted partner helping leading health club operators enable their digital transformation. We’re very excited to have found a business partner in Clubessential Holdings that shares our vision and commitment to exceptional customer service and will help accelerate our growth around the world."

For five years, Clubessential Holdings has developed a portfolio of companies, including ClubReady, Vermont Systems, PrestoSports, foreUP and Clubessential, offering a variety of forward-thinking technology and services which help more than 10,000 customers attract members, build loyalty, enhance operational efficiency, and deliver remarkable experiences. The acquisition of Exerp, in partnership with sister company ClubReady, positions Clubessential Holdings to serve over 6,000 fitness clubs globally.

"We’re thrilled to welcome Rémi, the Exerp team and their many outstanding fitness brands to Clubessential Holdings," said Randy Eckels, CEO. "Easy access to health & fitness resources, in the palm of your hand, has never been more important to gym members than it is today. We look forward to helping Exerp expand its central position as the enterprise platform of choice for assisting leading global fitness brands in their digital transformation initiatives."

Clubessential Holdings, LLC

Clubessential Holdings is a Battery Ventures company, fulfilling its global mission of investing in and creating cutting-edge, category-defining businesses by providing a full suite of membership and club management Software as a Service solutions to private clubs, public golf courses, health & fitness clubs, military organizations, municipalities, and college athletic programs. Across five brands – Clubessential, foreUP, ClubReady, PrestoSports, and Vermont Systems – the company offers a variety of forward-thinking technology and services which help more than 10,000 customers attract, engage, and retain club and community members and fans for life. For more information, visit the Clubessential Holdings website.

Exerp

Exerp, a Danish company founded in 2003, is an enterprise-level club-management software developer and servicer for the health and fitness Industry where it has specialised in solutions to meet the scalability, governance, and automation requirements of large, multi-site gym operators. Exerp’s business platform is built around a highly configurable back-end, offering unmatched flexibility as well as functional breadth to serve more than 6 million members at many of the largest operators in North America, EMEA and Australia. The Exerp platform offers a full-fledged API for seamless differentiation on top of a functional palette with more than 50 standard modules within subscription and price management, finance and billing, activity and resource bookings, communications, online services, DWH & BI, and branded member and staff mobile apps. Exerp’s software is supplied as a service, delivered and constantly optimised by an international team of data, application and implementation consultants. For more information, please visit www.exerp.com

Battery Ventures

Battery partners with exceptional founders and management teams developing category-defining businesses in markets including software and services, enterprise infrastructure, online marketplaces, healthcare IT and industrial technology. Founded in 1983, the firm backs companies at all stages, ranging from seed and early to growth and buyout, and invests globally from six strategic locations: Boston; San Francisco and Menlo Park, Calif.; Herzliya, Israel; London; and New York. Follow the firm on Twitter @BatteryVentures, visit our website at www.battery.com and find a full list of Battery’s portfolio companies here.

CONTACT:

Marilyn Cox
Vice President of Marketing
Clubessential Holdings, LLC
513.322.4194
mcox@clubessential.com

Related Images

image1.png

CGTN: True Colors Are shown in Crisis

BEIJING, May 15, 2021 — Crises are an unavoidable part of human history. And the response to a crisis can make a difference in a country’s development.

CGTN:True colors are shown in crisis
CGTN:True colors are shown in crisis

On May 12, 2008, a major earthquake jolted Wenchuan, a county of Sichuan Province in southwest China. The government’s speed in responding then amazed the world.

About 10 minutes after the disaster hit, China’s emergency response office issued a statement on the situation from Beijing, and the People’s Liberation Army (PLA) activated its preparedness plan.

Just 21 minutes after the quake, four helicopters were dispatched to survey the damage, and 6,100 officers and soldiers from neighboring areas and over 3,000 members of the Sichuan Armed Police Force deployed to the scene.

In less than 10 hours, 20,000 troops and armed police were at the disaster sites assisting with relief work, with an additional 34,000 security officers on their way.

The speed at which a government reacts to disasters speaks to its capacity to solve problems and its resilience.

COVID-19 has provided another stern test.

In the early stages of the outbreak, Wuhan in Hubei Province was in dire need of medics and equipment. The government rushed more than 330 medical teams comprising over 40,000 healthcare workers to the city.

Nineteen provinces were corralled to provide direct assistance to other surrounding provincial communities.

At first, the lockdown of Wuhan elicited confusion and even panic.

But the government provided timely updates and addressed the challenges that came with lockdown through grassroots community actions mobilized by local authorities.

In doing so, the spread of the virus was curbed and social stability maintained.

"I have never seen, in my life, this kind of mobilization," said World Health Organization Director-General Tedros Adhanom. "China’s speed, China’s scale and China’s efficiency… is the advantage of China’s system."

Not only did the government work on measures to tame COVID-19, but it also charted a 15-year socio-economic development blueprint.

China has proved itself adept at turning crises into opportunities.

"Roots of China’s Growth" is a 10-episode series marking the centenary of the founding of the Communist Party of China (CPC), which has presided over the country’s meteoric rise as a global power. The series focuses on 10 fundamental elements of the strategy that has led to China’s transformation from an impoverished nation over the past 100 years. This article is the first in the series.

https://news.cgtn.com/news/2021-05-12/Why-China-s-leadership-model-enables-quick-solutions-10ceG1ztKrm/index.html

 

Related Links :

http://www.cgtn.com

China’s Leading Big Data Expo to Start Online Show on May 20

GUIYANG, China, May 14, 2021 — 2021 China International Big Data Industry Expo (CIBDIE), the country’s leading big data expo, will be held in southwest China’s Guiyang City from May 26 to 28.

2021 China International Big Data Industry Expo (CIBDIE), the country's leading big data expo, will be held in southwest China's Guiyang City from May 26 to 28.
2021 China International Big Data Industry Expo (CIBDIE), the country’s leading big data expo, will be held in southwest China’s Guiyang City from May 26 to 28.

The event integrates online and offline participation, featuring conferences, exhibitions, new product launches, contests and other activities. A professional exhibition will be held both online and offline, with the online event to be kicked off on May 20, according to China International Big Data Industry Expo Organizing Committee.

The online exhibition has attracted many big data enterprises at home and abroad since its opening for registration.

Industry giants at home and abroad, such as NTT Data, Baishan Cloud, King Base and DT Dream have registered for the event. More than 260 big data industry enterprises have applied for participation in the online exhibition so far.

The online exhibition platform will showcase the brand features and star exhibits of hundreds of participating enterprises through videos, pictures, texts, and gather guests and professionals from all over the world to meet online.

Meanwhile, the system can offer related information of exhibitors or exhibits according to online visitors’ preferences, boosting the accuracy and effectiveness in obtaining information. Besides, to build a friendly online interaction platform for exhibitors and visitors, the online exhibition will also provide e-business-card exchange, negotiation and appointment, schedule management and other interactive scenarios.

In order to facilitate global participation, the online exhibition will roll out an English version, enabling exhibitors and audiences at home and abroad to switch the language versions according to their needs.

Along with the online exhibition, the offline exhibition will open on May 26 and last for three days.

For more information, please visit: https://www.bigdata-expo.cn/

Image Attachments Links:
Link: http://asianetnews.net/view-attachment?attach-id=391211 
Caption: 2021 China International Big Data Industry Expo (CIBDIE), the country’s leading big data expo, will be held in southwest China’s Guiyang City from May 26 to 28.

PMB and CEA Announce the Commissioning of iMiGiNE at Frederic Joliot Hospital (Orsay), Paving the Way for Next Generation Molecular Imaging Diagnostics


PEYNIER, France, May 12, 2021 — An automated radiopharmaceutical production system iMiGiNE has been installed in Frederic Joliot Hospital (CEA) in Orsay, France and commissioned in December 2020. This disruptive system will revolutionize the radiopharmaceutical production, access and distribution. iMiGiNE will allow clinical centers to directly access disease-specific radiopharmaceuticals, otherwise rarely available, and take a first step towards personalized molecular imaging.

To view the Multimedia News Release, please click: 
https://www.multivu.com/players/uk/8894551-imigine-a-paradigm-shift-in-the-production-of-radiopharmaceuticals/

jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”
 

jwplayer(‘myplayer1’).setup({file: ‘https://www.youtube.com/watch?v=jOYvDZX-3Rc’, image: ‘http://www.prnasia.com/video_capture/3370122_AE70122_1.jpg’, autostart:’false’, aspectratio: ’16:9′, stretching : ‘fill’, width: ‘600’, height: ‘338’});

A shift in paradigm: microfluidic syntheses

iMiGiNE uses groundbreaking technology to produce radiopharmaceuticals: a single-use lab-on-a-chip device, with onboard precursors and solvents. Offering lower volumes and higher yields, this versatile microfluidic cassette can be used for process or tracer development as well as the production of single doses or small batches. It is integrated in a radiosynthesis box, a closed system to prevent cross contamination, operated by a robotized arm, and controlled through a supervision software.

An automated manufacturing process, from radiopharmaceutical selection to a filled syringe

iMiGiNE combines a cyclotron equipped with a superconducting magnet, making it more stable and compact, and a robotized radiochemistry to produce the selected radiopharmaceutical. Operated through a user-friendly supervision software, the cyclotron produces the selected radioisotope, which is then transferred to the radiochemistry for radiolabeling.

Unlocking the full potential of precision medicine

Only a few of more than a hundred molecules of clinical interest are used today in routine PET imaging. Why? Cumbersome processes and infrastructures, and costly manufacturing operations. Additionally, the use of some radioisotopes with a short half-life is challenging for smaller centers (110 min for 18F and only 20 min for 11C). iMiGiNE can break those barriers by relocating the production of radiopharmaceuticals close to the patient, and ultimately improving patient care. 

About PMB

PMB is a human-sized company located near Aix-en-Provence, in the south of France, specialized in the design and manufacture of complex particle accelerators systems for Medical, Research, Nuclear, Defense and Industry applications.

Historically, PMB started with the specialty of assembling dissimilar materials such as metals and ceramics. Since 2010, we have developed complex systems integrating particle accelerators. Among others, an automated system that produces in-house PET radiopharmaceuticals and linear accelerators for non-destructive testing (high-energy radiography), and radiotherapy. PMB is part of the French industrial group ALCEN.

About CEA

The CEA is a key player in research, development and innovation in four main areas: energy transition, digital transition, technology for the medicine of the future and defense and security. The CEA carries out fundamental research in the fields of Biotechnology and Health, the Physical Sciences, Earth Sciences and Astronomy, Physics and Nanoscience. Its core objectives are the production and publication of knowledge and expertise at the highest international level. In 2019, nearly 3,800 scientific papers were published by CEA researchers, three-quarters of which were the result of international collaboration. The CEA draws on all this knowledge to carry out its other activities. 

For more information about PMB and CEA, please visit www.pmb-alcen.com / www.cea.fr

Additional information about iMiGiNE can be found at www.imigine.com or follow PMB-Alcen on LinkedIn. 

PET Radiopharmaceutical Development & Production
PET Radiopharmaceutical Development & Production

 

 

Contact:
Fatine Slaoui
contact@pmb-alcen.com
+33 4 42 53 13 13

 

Related Links :

https://www.pmb-alcen.com/

DiA Imaging Analysis Partners with SonoScape Medical Corporation to Deliver Cardiac Ultrasound AI solutions


BE’ER SHEVA, Israel, and SHENZHEN, China , May 11, 2021DiA Imaging Analysis Ltd. (DiA), a leading provider of AI-powered ultrasound analysis solutions today announced that it has partnered with SonoScape Medical Corporation  (300633.SZ), a leading developer and manufacturer of ultrasound systems. As part of the partnership, SonoScape’s ultrasound devices will provide DiA’s ultrasound artificial intelligence analysis solutions aiming to reduce the variability associated with manual or visual analysis, and increase efficiency and accuracy throughout the analysis process.

A recent survey indicated that 85% of ultrasound users said that AI saved their practice time and 69% reported that it saved costs. By providing automated ultrasound AI solutions, this partnership fills the growing need for objective and accurate analysis in this booming market where ultrasound analysis is often done in a subjective and time-consuming method – by visual or manual estimations.

"SonoScape is committed to delivering outstanding services to its ultrasound users to help increase their efficiency," said Dr. Nai Zhang Feng, General Manager of Ultrasound Division at SonoScape. "By joining hands with DiA, we will enhance our users’ capabilities with the most innovative technology of cardiac ultrasound AI tools."

DiA’s FDA cleared and CE marked AI-based cardiac solutions, LVivo Toolbox™, were developed by a proprietary technology that imitates the way the human eye detects borders and identifies motion, therefore, allowing ultrasound users with various levels of experience automatically analyze and identify clinical abnormalities that are otherwise difficult to find visually.

"We are thrilled to partner with SonoScape to empower their users with our most advanced ultrasound AI solutions," said Hila Goldman – Aslan, CEO and Co-Founder of DiA Imaging Analysis. "Combining SonoScape’s ultrasound capacities with DiA’s AI technology is another great step forward to make the analysis of ultrasound images smarter and accessible to all."

About DiA Imaging Analysis

DiA Imaging Analysis is a leading provider of AI-powered ultrasound analysis solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. The company’s FDA cleared and CE marked LVivo™ product line for cardiac and abdominal auto analysis allow clinicians with various levels of ultrasound experience to use and analyze ultrasound images on their ultrasound devices or healthcare IT systems with increased speed, efficiency and accuracy. DiA currently serves thousands of end users worldwide. 
For additional information, please visit www.dia-analysis.com .

About SonoScape

SonoScape Medical Corp. manufactures medical equipment. The Company develops, produces, and sells ultrasound diagnostic systems, transducers, and other medical equipment products. SonoScape Medical serves customers worldwide.

Founded in 2002 in Shenzhen, China, SonoScape has committed itself to "Caring for life through innovation" by providing ultrasound and endoscopy solutions and delivering first-rate services. It now has seven R&D centers in Shenzhen, Shanghai, Harbin, Wuhan, Tokyo, Silicon Valley and Seattle. Ranked as the top 10 ultrasound brands globally, SonoScape invests heavily into R&D annually, with more advanced products to be introduced into the pipeline.

Contact:
Tal Sacharov
VP Marketing
DiA Imaging Analysis
tal.sacharov@dia-analysis.com  
www.dia-analysis.com 

Logo – https://techent.tv/wp-content/uploads/2021/05/dia-imaging-analysis-partners-with-sonoscape-medical-corporation-to-deliver-cardiac-ultrasound-ai-solutions.jpg  

 

 

Related Links :

http://www.dia-analysis.com

Aaseya Receives the Client Innovation Award for Social Responsibility from Pega


HYDERABAD, India, May 8, 2021 — Aaseya, Pega Gold Partner, received the Client Innovation Award for Social Responsibility from Pegasystems at PegaWorld iNspire 2021. This prestigious award from Pega recognizes Aaseya for the excellence in delivery and innovation of a COVID-19 rapid response solution for StepChange Debt Charity.

The solution developed on the Pega Platform™ and Pega Customer Service supports up to 10,000+ concurrent users hosted on Pega Cloud.  It facilitates the end-to-end processing of applications for financial relief due to the COVID-19 debt situation.

Quickly designed and built within weeks, the StepChange CVPP product assesses candidate suitability with six online questions. Those that qualify are routed to complete a more detailed income and expenditure analysis that helps StepChange develop its assistance plan. CVPP also leverages Pega Chat to support online conversations between the applicant and StepChange experts.

Commenting on the award, Pankaj Jain, Aaseya CEO, said, "We are honored to receive this award from Pega. It is testimony to the in-depth Pega expertise, cross-industry domain knowledge, and consultative delivery capabilities of the 400+ strong Aaseya professional services team. In the last three and half years, we have come to be recognized as a partner of choice for clients who look to engage a transformative provider of Pega solutions and services." Adrian Bignall, Global Head of Sales & Customer Success for Aaseya, said, "We are privileged to receive this award as well as being able to support StepChange, who deliver a vital service to UK Citizens at this challenging time."

"Pega is pleased to present the Client Innovation Award for Social Responsibility to Aaseya for the outstanding work they have delivered to our joint customer StepChange Debt Charity. We look forward to growing our partnership with Aaseya during 2021," said Carola Cazenave, vice president, global partner ecosystem, Pegasystems.

About Aaseya

Aaseya is a leading professional services company specialising in Digital Transformation through the rapid delivery of Low Code and Digital / Robotic Process Automation Technologies. Aaseya’s 400 consultants specialise in the agile delivery of the Pega Platform, delivering faster time-to-business value for their customers. Aaseya’s Gold Partnership status with Pega is based on its significant Pega Practice size and the large number of successful Pega implementations.

Aaseya operates in 10 countries, working with Banking, Insurance, Manufacturing, and Government organisations, delivering innovative enterprise solutions in the areas of Customer Experience, Business Operations, Legacy Modernization, Case Management, and CRM. Aaseya is a subsidiary of YASH Technologies, a Global System Integrator, with 6,000 employees serving 400 customers globally, specialising in delivering business transformation through IT. 

Visit us at www.aaseya.com and www.yash.com